Daniel Spiegelman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Spiegelman
Daniel Spiegelman is recorded as CFO at Biomarin Pharmaceutical Inc (BMRN). The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $5,239,902 for Daniel Spiegelman in fiscal 2019, including a base salary of $620,192. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara Bodem Board Member
- Barbara W. Bodem Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Biomarin Pharmaceutical Inc (BMRN) | Former Executive Vice President, Chief Financial Officer | $620,192 | $5,239,902 |
| 2018 | Biomarin Pharmaceutical Inc (BMRN) | Former Executive Vice President, Chief Financial Officer | $593,269 | $4,521,703 |
| 2017 | Biomarin Pharmaceutical Inc (BMRN) | Former Executive Vice President, Chief Financial Officer | $559,231 | $4,641,875 |
Recent activity
No call appearances or filed executive changes recorded yet.